Showing 1011-1020 of 4012 results for "".
Society for Gynecologic Investigation
https://reachmd.com/programs/clinicians-roundtable/society-for-gynecologic-investigation/836/Although largely unheralded, professional societies provide valuable networks to support and expand research. Learn about some of the remarkable discoveries at the cutting edge of obstetrics and gynecology from the President of Society for Gynecolgoic Investigation--the foremost association of reseLessons from 1993: Hillary Clinton's health care
https://reachmd.com/programs/clinicians-roundtable/lessons-from-1993-hillary-clintons-health-care/505/Marilyn Werber Serafini of National Journal talks about Hillary Clinton's health care experience in 1993 when she headed a health care commission for her husband Bill Clinton, and now as she moves forward with her own presidential campaign.Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
https://reachmd.com/programs/medical-industry-feature/treating-mild-cognitive-impairment-in-alzheimers-disease/37126/Alzheimer’s disease is a progressive, relentless disease caused by a continuous underlying neurotoxic process.1,2 A key hallmark of the disease is the abnormal accumulation of amyloid beta, which builds up in two forms: insoluble plaques and toxic soluble protofibrils.3-5 LEQEMBI® (lecanemab-irmb),"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
https://reachmd.com/programs/the-convergence/Michal-Nedoszytko-PostVisit-ai/54781/The next wave of AI innovation is here, and clinicians are at the forefront. Dr. Brian McDonough sits down with Dr. Michal Nedoszytko, an interventional and general cardiologist and the creator of PreVisit.ai and PostVisit.ai, to learn how he's turning everyday clinical challenges into AI-driven sAdvances in Parenteral Nutrition: Examining Multi-Source Lipid Emulsions
https://reachmd.com/programs/gi-insights/advances-parenteral-nutrition-multi-source-lipid-emulsions/37244/Evolving evidence supports the shift from single-source to multi-source intravenous lipid emulsions in parenteral nutrition. These newer formulations may offer improved metabolic, inflammatory, and hepatic outcomes, particularly for vulnerable patient populations. Joining Dr. Charles Turck to discusInformed Consent
https://reachmd.com/programs/clinicians-roundtable/informed-consent-1/844/Dr. Michael Greenberg welcomes Dr. James Gottesman as he discusses how using a computer generated consent and information forms can help reduce physician stress.Roflumilast Cream, 0.15%, for Atopic Dermatitis
https://reachmd.com/issues/december-2024/Roflumilast-Cream-Atopic-Dermatitis/32840/Atopic dermatitis (AD) is a chronic, persistent inflammatory condition that significantly disrupts the quality of life of patients diagnosed with it. Moreover, AD presents challenges for clinicians when counseling patients on the management of their condition. Application frequency, treatment formulManaging IBD as an Athlete: An NBA Pro's Perspective
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/managing-ibd-athlete-nba-pros-perspective/9643/Former NBA player Dajuan Wagner chats about the challenges facing athletes dealing with IBD.Electromagnetic Therapy Improves Survival in Patients with Aggressive Type of Brain Cancer
https://reachmd.com/programs/the-jama-report/electromagnetic-therapy-improves-survival-patients-aggressive-type-brain-cancer/7863/[Read the Article] Glioblastoma is the most devastating form of brain cancer in adults; most patients die within one to two years of diagnosis. A new study examined whether using tumor-treating fields, a type of electromagnetic therapy, combined with maintenance chemotherapy in patients with glioblaUnderstanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
https://reachmd.com/programs/heart-matters/understanding-lipid-and-lipoprotein-metabolism-in-cardiovascular-health/39734/Understanding how lipids and lipoproteins are formed, metabolized, and cleared is essential for accurate lipid interpretation and cardiovascular risk assessment. Hear from Dr. Robert Eckel as he explains these molecular mechanisms and implications for patient management. Dr. Eckel is a Professor Eme